NEW YORK (CBSNewYork) – There’s new hope for cat lovers who are allergic to their furry friends.
A team of scientists in Switzerland are working on a vaccine targeting a major feline allergen, called Fel d 1.READ MORE: Sneak Peek: Lincoln Center Plaza Transformed Into Green Space For Outdoor Summer Performances
Researchers say nearly 10 percent of the western population is affected by cat allergies.
Their vaccine is called “HypoCat” and it works by giving cats the vaccine – not their allergic owners.READ MORE: Police Make Arrests In Shooting Death Of 1-Year-Old Davell Gardner Jr. In Brooklyn
MORE NEWS: Stimulus Check Update: Is A Fourth Relief Payment In Your Future?
News for patients with cat allergy: A study provides evidence that cat vaccination against the major cat allergen Fe1 d 1 can reduce Fel d 1 level in cat secretions and potentially minimize its ability to cause a human allergic response. https://t.co/0QhH4kJ33M
— Journal of Allergy and Clinical Immunology (@jacionline) August 8, 2019
“Both human subjects and animals could profit from this treatment because allergic cat owners would reduce their risk of developing chronic diseases, such as asthma, and become more tolerant of their cats, which therefore could stay in the households and not need to be relinquished to animal shelters,” the researchers said in the Journal of Allergy and Clinical Immunology.